Celiac disease screening: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Raviteja Reddy Guddeti (talk | contribs)
nocaptcha
20,348 edits
No edit summary
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Bot: Removing from Primary care
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Celiac disease}}
{{Celiac disease}}
{{CMG}}
{{CMG}};{{AE}}{{MehdiP}}


==Overview==
==Overview==
Screening with [[tissue transglutaminase]] (tTG) IgA test is recommended for symptomatic high risk celiac disease patients.
==Screening==
==Screening==
There is significant debate as to the benefits of [[Screening (medicine)|screening]]. Some studies suggest that early detection would decrease the risk of osteoporosis and anaemia. In contrast, a [[cohort study|cohort studied]] in Cambridge suggested that people with undetected coeliac disease had a beneficial risk profile for [[cardiovascular disease]] (less [[overweight]], lower [[cholesterol]] levels).
*Screening in asymptomatic celiac disease patients is not recommended.<ref name="pmid28350935">{{cite journal |vauthors=Chou R, Bougatsos C, Blazina I, Mackey K, Grusing S, Selph S |title=Screening for Celiac Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force |journal=JAMA |volume=317 |issue=12 |pages=1258–1268 |year=2017 |pmid=28350935 |doi=10.1001/jama.2016.10395 |url=}}</ref>
*Screening is recommended for symptomatic and high risk patients with positive family history in first and second degree relatives as well as in patients with other [[autoimmune diseases]] such as, [[Diabetes mellitus type 1|type 1 diabetes mellitus]], inflammatory luminal gastrointestinal disorders, [[Down syndrome]], [[Turner syndrome]], [[IgA deficiency]], and [[IgA nephropathy]].<ref name="pmid28350935">{{cite journal |vauthors=Chou R, Bougatsos C, Blazina I, Mackey K, Grusing S, Selph S |title=Screening for Celiac Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force |journal=JAMA |volume=317 |issue=12 |pages=1258–1268 |year=2017 |pmid=28350935 |doi=10.1001/jama.2016.10395 |url=}}</ref>
*Screening method for celiac disease is tissue transglutaminase (tTG) IgA test.


Due to its high sensitivity, [[serology]] has been proposed as a screening measure, because the presence of antibodies would detect previously undiagnosed cases of coeliac disease and prevent its complications in those patients. Serology may also be used to monitor adherence to diet: in those who still ingest gluten, antibody levels remain elevated.
==References==


Clinical scenarios in which screening may be justified include type 1 diabetes unexplained iron-deficiency anemia,<ref>{{cite journal |author=Corazza G, Valentini R, Andreani M, D'Anchino M, Leva M, Ginaldi L, De Feudis L, Quaglino D, Gasbarrini G |title=Subclinical coeliac disease is a frequent cause of iron-deficiency anaemia |journal=Scand J Gastroenterol |volume=30 |issue=2 |pages=153–6 |year=1995 |pmid=7732338}}</ref><ref>{{cite journal |author=Ransford R, Hayes M, Palmer M, Hall M |title=A controlled, prospective screening study of celiac disease presenting as iron deficiency anemia |journal=J Clin Gastroenterol |volume=35 |issue=3 |pages=228&ndash;33 |year=2002 |pmid=12192198}}</ref> [[Down's syndrome]], [[Turner's syndrome]], [[irritable bowel syndrome]], [[Lupus erythematosus|lupus]], and autoimmune thyroid disease.<ref>{{cite journal |author=Sjöberg K, Carlsson A |title=Screening for celiac disease can be justified in high-risk groups |journal=Lakartidningen |volume=101 |issue=48 |pages=3912, 3915–6, 3918&ndash;9 |year=2004 |pmid=15631226}}</ref>
{{Reflist|2}}
 
==Refernces==
{{reflist|2}}


{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Gastroenterology]]
[[Category:Rheumatology]]
[[Category:Autoimmune diseases]]
[[Category:Genetic disorders]]
[[Category:Malnutrition]]
[[Category:Pediatrics]]
[[Category:Dermatology]]
[[Category:Up-To-Date]]

Latest revision as of 20:51, 29 July 2020

Celiac disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Celiac disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modifications
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Celiac disease screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Celiac disease screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Celiac disease screening

CDC on Celiac disease screening

Celiac disease screening in the news

Blogs onCeliac disease screening

Directions to Hospitals Treating Celiac disease

Risk calculators and risk factors for Celiac disease screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Screening with tissue transglutaminase (tTG) IgA test is recommended for symptomatic high risk celiac disease patients.

Screening

References

  1. ↑ 1.0 1.1 Chou R, Bougatsos C, Blazina I, Mackey K, Grusing S, Selph S (2017). "Screening for Celiac Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force". JAMA. 317 (12): 1258–1268. doi:10.1001/jama.2016.10395. PMID 28350935.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Celiac_disease_screening&oldid=1635809"